Economic TimesLean R·
Dr Reddy’s shares crack 9% after weak Q1; these 3 brokerages slash their target prices
Shares of Dr Reddy’s tanked 9% to Rs 1,080 on the BSE on Thursday after the company announced a weak set of numbers with profitability and revenue both dipping in the first quarter of the financial year 2027. The company’s net profit was Rs 443 crore, marking a sharp 69% plunge for the quarter under review, while revenue from operations stood at Rs 8,071 crore, a 6% decline from the corresponding quarter of the previous financial year. Dr Reddy's said that the company faced a semaglutide API-re…
Read at Economic Times →
